Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cepharanthin, a multidrug resistant modifier, is a substrate for P-glycoprotein

M Hirai1, K Tanaka, T Shimizu

  • 1Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Japan.

The Journal of Pharmacology and Experimental Therapeutics
|October 1, 1995
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impaired tetramer assembly of variant medium-chain acyl-coenzyme A dehydrogenase with a glutamate or aspartate substitution for lysine 304 causing instability of the protein.

The Journal of biological chemistry·1992
Same author

The prognostic value of cytogenetic analyses in patients with acute nonlymphocytic leukemia treated with the same intensive chemotherapy.

Cancer·1992
Same author

Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination.

Nature·1992
Same author

[Antitumor effect of locally injected TNF.fibrin gel against murine colon 26 subcutaneous tumor: preliminary report].

Nihon Geka Gakkai zasshi·1992
Same author

[Clinical studies on cefprozil granules in pediatric skin soft tissues infections].

The Japanese journal of antibiotics·1992
Same author

Generalized resistance to thyroid hormone (GRTH) in a family: case studies.

Endocrinologia japonica·1992

Cepharanthin effectively reverses multidrug resistance by inhibiting P-glycoprotein, a key transporter in cancer chemotherapy. Combining it with other modulators may enhance its efficacy against anticancer drug expulsion.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • P-glycoprotein (P-gp) mediates multidrug resistance (MDR) in cancer chemotherapy.
  • Existing P-gp modulators often require high doses with undesirable side effects.

Purpose of the Study:

  • To investigate the efficacy of cepharanthin as a P-gp modulator.
  • To evaluate cepharanthin's role in reversing MDR and its interaction with other modulators.

Main Methods:

  • Utilized LLC-GA5-COL150 cells expressing P-gp on apical membranes.
  • Examined the transport of anticancer drugs (vinblastine, daunorubicin) mediated by P-gp.
  • Assessed cepharanthin's inhibitory concentration and its transport characteristics.

Main Results:

Related Experiment Videos

  • Cepharanthin potently inhibited vinblastine and daunorubicin transport (IC50 for daunorubicin = 2.06 microM).
  • Cepharanthin itself is transported by P-gp in a saturable manner.
  • Combined administration with cyclosporin A showed synergistic effects on daunorubicin transport inhibition.

Conclusions:

  • Cepharanthin demonstrates significant potential as a P-gp modulator for reversing MDR.
  • Combination therapy with other P-gp modulators may enhance the inhibition of anticancer drug efflux.